ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 24 Issue : 2
Current Issue Archive Popular Article Ahead of Print

 
Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population [Anatol J Cardiol]
Anatol J Cardiol. 2017; 17(1): 66-72 | DOI: 10.14744/AnatolJCardiol.2016.6679  

Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population

Ayşe Esra Koku Aksu1, Zeynep Nurhan Saraçoğlu2, Selma Metintaş3, İlham Sabuncu2, Yıldız Çetin4
1Department of Dermatology, İstanbul Training and Research Hospital, İstanbul-Turkey
2Departments of Dermatology, Eskişehir Osmangazi University, Eskisehir-Turkey
3Public Health, Eskişehir Osmangazi University, Eskisehir-Turkey
4Department of Dermatology, Kent Hospital, Kütahya-Turkey

Objective: Psoriasis is associated with an increased frequency of cardiovascular risk factors. Metabolic syndrome (MS) and the Framingham risk score (FRS) are two different algorithms for evaluating cardiovascular risk. They include different features: waist circumference measurement is included in the MS criteria, whereas smoking, age, and gender are questioned in FRS. This study aimed to evaluate the frequency of MS and FRS in psoriasis patients compared with a control group and investigate the differences between MS and FRS.
Methods: This was a cross-sectional study involving 300 psoriasis patients and 177 controls. MS, FRS, and disease severity were evaluated.
Results: The frequency of MS was higher in females with psoriasis than in those in the control group (p=0.019). Females in the psoriasis group were more obese than those in the control group (p=0.036). FRS significantly differed between the patients and controls of age >60 years (p=0.006). The risk of hypertension in current and past smokers was higher in the psoriasis patients (OR=2.07 and 2.32–2.48, respectively) than in the control group. There was no statistically significant relationship among MS, FRS, and psoriasis severity (p>0.05).
Conclusion: The results of this study support the evaluation of cardiovascular risk assessment in female psoriasis patients with MS and in male and elderly psoriasis patients with FRS. (Anatol J Cardiol 2017; 17: 66-72)

Keywords: Framingham risk score, metabolic syndrome, psoriasis


Ayşe Esra Koku Aksu, Zeynep Nurhan Saraçoğlu, Selma Metintaş, İlham Sabuncu, Yıldız Çetin. Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: A cross-sectional study in the Turkish population. Anatol J Cardiol. 2017; 17(1): 66-72

Corresponding Author: Ayşe Esra Koku Aksu, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2019 Turkish Society of Cardiology